0000313143-14-000024.txt : 20140210 0000313143-14-000024.hdr.sgml : 20140210 20140210134727 ACCESSION NUMBER: 0000313143-14-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140207 FILED AS OF DATE: 20140210 DATE AS OF CHANGE: 20140210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Jonathan CENTRAL INDEX KEY: 0001457882 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 14587651 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION INCORPORATED STREET 2: 400 WOOD ROAD CITY: BRAINTTREE STATE: MA ZIP: 02184 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-02-07 0 0000313143 HAEMONETICS CORP HAE 0001457882 White Jonathan 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 0 Chief Science and Technology Common Stock 2014-02-07 4 S 0 700.0 38.66 D 26346 D Common Stock 2014-02-07 4 S 0 315.0 38.672 D 26031 D Common Stock 2014-02-07 4 S 0 865.0 38.66 D 25166 D Non-Qualified Stock Option (right to buy) 26.47 2010-10-27 2016-10-27 Common Stock 24484 24484 D Non-Qualified Stock Option (right to buy) 27.495 2011-10-27 2017-10-27 Common Stock 30776 30776 D Non-Qualified Stock Option (right to buy) 30.025 2010-01-28 2016-01-28 Common Stock 35282 35282 D Non-Qualified Stock Option (right to buy) 30.67 2012-10-25 2018-10-25 Common Stock 35130 35130 D Non-Qualified Stock Option (right to buy) 33.925 2012-07-20 2018-07-20 Common Stock 27948 27948 D Non-Qualified Stock Option (right to buy) 39.055 2013-10-24 2019-10-24 Common Stock 32192 32192 D Non-Qualified Stock Option (right to buy) 41.66 2014-10-23 2019-10-23 Common Stock 28523 28523 D Performance Shares 0.0 2017-03-31 2017-12-31 Common Stock 25000 25000 D Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d). By: Alexander Steffan For: Jonathan White 2014-02-10